ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
iSERA Lifesciences has scheduled its 34th Annual General Meeting for September 29, 2026, and appointed a scrutinizer to oversee the voting process for the event.
iSERA Lifesciences issued a corrigendum to its Postal Ballot notice. It clarifies preferential equity share allotments and post-issue capital percentages.
iSERA Lifesciences Limited released its postal ballot scrutinizer report. Shareholders approved resolutions including share capital increases and related party transactions with requisite majority support.
iSERA Lifesciences Limited issued a postal ballot notice seeking approval for several matters, including a ₹78 Crore acquisition of iSERA Biological Limited via share swap. Other items include increasing authorised share capital to ₹25 Crore and adopting new articles and memorandum of association. Remote e-voting runs from April 22 to May 21, 2026.